Evidence map›Paper›PMID 36626307›Full record

ArticleeLife2023

Unconventional secretion of α-synuclein mediated by palmitoylated DNAJC5 oligomers.

Shenjie Wu, Nancy C Hernandez Villegas, Daniel W Sirkis, Iona Thomas-Wright, Richard Wade-Martins, Randy Schekman

Open access · goldAbstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. N-type CaNPJ Parkinson's disease · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Shenjie WuDepartment of Molecular and Cell Biology, Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, United States.ORCID 0000-0001-7547-0048
Nancy C Hernandez VillegasHelen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, United States.ORCID 0000-0002-3982-7553
Daniel W SirkisMemory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, United States.ORCID 0000-0003-3440-8859
Iona Thomas-WrightOxford Parkinson's Disease Centre, Department of Physiology, Anatomy and Genetics and Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford, United Kingdom.
Richard Wade-MartinsOxford Parkinson's Disease Centre, Department of Physiology, Anatomy and Genetics and Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford, United Kingdom.
Randy SchekmanDepartment of Molecular and Cell Biology, Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, United States.ORCID 0000-0001-8615-6409
Howard Hughes Medical Institute · USUniversity of Oxford · GBUniversity of California, Berkeley · USUniversity of California, San Francisco · US

Funding

Biology and Biotechnology of Cell and Gene TherapyT32GM139780 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI Amy Elizabeth Herr, Dirk Hockemeyer · 2021 to 2026
$2.4M
Howard Hughes Medical InstituteMedical Research Council MC_EX_MR/N50192X/1Medical Research Council MR/L023784/2Medical Research Council MR/M024962/1Medical Research Council MR/N029453/1Medical Research Council MR/P007058/1NIGMS NIH HHS T32 GM139780NIH HHS NIH training program T32GM139780Parkinson's UK G-0801Parkinson's UK G-1003Parkinson's UK H-1102Parkinson's UK H-1301Parkinson's UK J-0901Parkinson's UK K-1003
6 · The paper itself

Abstract

Alpha-synuclein (α-syn), a major component of Lewy bodies found in Parkinson's disease (PD) patients, has been found exported outside of cells and may mediate its toxicity via cell-to-cell transmission. Here, we reconstituted soluble, monomeric α-syn secretion by the expression of DnaJ homolog subfamily C member 5 (DNAJC5) in HEK293T cells. DNAJC5 undergoes palmitoylation and anchors on the membrane. Palmitoylation is essential for DNAJC5-induced α-syn secretion, and the secretion is not limited by substrate size or unfolding. Cytosolic α-syn is actively translocated and sequestered in an endosomal membrane compartment in a DNAJC5-dependent manner. Reduction of α-syn secretion caused by a palmitoylation-deficient mutation in DNAJC5 can be reversed by a membrane-targeting peptide fusion-induced oligomerization of DNAJC5. The secretion of endogenous α-syn mediated by DNAJC5 is also found in a human neuroblastoma cell line, SH-SY5Y, differentiated into neurons in the presence of retinoic acid, and in human-induced pluripotent stem cell-derived midbrain dopamine neurons. We propose that DNAJC5 forms a palmitoylated oligomer to accommodate and export α-syn.

Indexed as

NeuroblastomaParkinson Diseasealpha-SynucleinDopaminergic NeuronsHEK293 CellsHSP40 Heat-Shock ProteinsHumansMembrane Proteinsalpha-Synucleincysteine string proteinHSP40 Heat-Shock ProteinsMembrane Proteinsalpha-synucleincell biologyDNAJC5humanneurosciencepalmitoylationparkinson's diseasetraffickingunconventional secretion

Identifiers

PMID36626307
PMCPMC9876576
OpenAlexW4313988037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.